1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Mid-Size Pharmaceutical – By Type

1.3.2        APAC Mid-Size Pharmaceutical – By Drug Development Type

1.3.3        APAC Mid-Size Pharmaceutical – By Formulation

1.3.4        APAC Mid-Size Pharmaceutical – By Therapy Area

1.3.5        APAC Mid-Size Pharmaceutical – By Country

2.           Mid-Size Pharmaceutical– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Mid-Size Pharmaceutical – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Expert Opinion

5.           Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Disorders

5.1.2        Increasing Product Approval and Launches

5.2         Market Restraints

5.2.1        High Competition Among Market Players

5.3         Market Opportunities

5.3.1        Rising Number of Healthcare Start-ups

5.4         Future Trends

5.4.1        Increasing Focus on R&D

5.5         Impact Analysis

6.           Mid-Size Pharmaceutical Market– APAC Analysis

6.1         APAC Mid-Size Pharmaceutical Market Revenue Forecast And Analysis

7.           APAC Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type

7.1         Overview

7.2         APAC Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

7.3         Prescription

7.3.1        Overview

7.3.2        Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Over-the-Counter (OTC)

7.4.1        Overview

7.4.2        Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.           APAC Mid-Size Pharmaceutical Market Analysis – By Drug Development Type

8.1         Overview

8.2         APAC Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

8.3         In-House

8.3.1        Overview

8.3.2        In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Outsource

8.4.1        Overview

8.4.2        Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.           APAC Mid-Size Pharmaceutical Market – By Formulation

9.1         Overview

9.2         APAC Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

9.3         Tablets and Capsules

9.3.1        Overview

9.3.2        Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Injectables

9.4.1        Overview

9.4.2        Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Sprays

9.5.1        Overview

9.5.2        Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Formulations

9.6.1        Overview

9.6.2        Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.        APAC Mid-Size Pharmaceutical Market – By Therapy Class

10.1      Overview

10.2      APAC Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

10.3      Cardiovascular Diseases

10.3.1     Overview

10.3.2     Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Pain Management

10.4.1     Overview

10.4.2     Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Diabetes

10.5.1     Overview

10.5.2     Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cancer

10.6.1     Overview

10.6.2     Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Other Diseases

10.7.1     Overview

10.7.2     Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.        APAC Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     APAC: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%)

11.1.1.1       China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2       China: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)

11.1.1.1.3       China: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)

11.1.1.1.4       China: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.1.5       China: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

11.1.1.2       Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2       Japan: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)

11.1.1.2.3       Japan: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)

11.1.1.2.4       Japan: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.2.5       Japan: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

11.1.1.3       India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2       India: Mid-Size Pharmaceutical Market, By Type , 2019–2028 (USD Million)

11.1.1.3.3       India: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)

11.1.1.3.4       India: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.3.5       India: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

11.1.1.4       Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.1       Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.2       Australia: Mid-Size Pharmaceutical Market , By Type , 2019–2028 (USD Million)

11.1.1.4.3       Australia: Mid-Size Pharmaceutical Market , By Drug Development Type , 2019–2028 (USD Million)

11.1.1.4.4       Australia: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.4.5       Australia: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

11.1.1.5       South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.1       South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.2       South Korea: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)

11.1.1.5.3       South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type , 2019–2028 (USD Million)

11.1.1.5.4       South Korea: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.5.5       South Korea: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

11.1.1.6       Rest of APAC: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.1       Rest of APAC: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.2       Rest of APAC: Mid-Size Pharmaceutical Market, By Type, 2019–2028 (USD Million)

11.1.1.6.3       Rest of APAC: Mid-Size Pharmaceutical Market, By Drug Development Type, 2019–2028 (USD Million)

11.1.1.6.4       Rest of APAC: Mid-Size Pharmaceutical Market, By Formulation, 2019–2028 (USD Million)

11.1.1.6.5       Rest of APAC: Mid-Size Pharmaceutical Market, By Therapy Area, 2019–2028 (USD Million)

12.        Mid-Size Pharmaceutical Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      DAIICHI SANKYO COMPANY LIMITED

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Eisai Co., Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bausch Health Companies Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Regeneron Pharmaceuticals, Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sun Pharmaceutical Industries Ltd

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Mallinckrodt

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Endo Pharmaceuticals Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             China: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             China: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and forecast to 2028 (USD Million)

Table 3.             China: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan: Mid-Size Pharmaceutical Market , By Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India: Mid-Size Pharmaceutical Market, By Formulation - Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Mid-Size Pharmaceutical Market, By Therapy Area– Revenue and Forecast to 2028 (USD Million)

Table 13.          Australia: Mid-Size Pharmaceutical Market , By Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)

Table 17.          South Korea: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of APAC: Mid-Size Pharmaceutical Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of APAC: Mid-Size Pharmaceutical Market, By Drug Development Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of APAC: Mid-Size Pharmaceutical Market, By Formulation – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of APAC: Mid-Size Pharmaceutical Market, By Therapy Area – Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms

LIST OF FIGURES

Figure 1.           APAC Mid-Size Pharmaceutical Segmentation

Figure 2.           APAC Mid-Size Pharmaceutical Segmentation, By Country

Figure 3.           APAC Mid-Size Pharmaceutical Overview

Figure 4.           Over-the-Counter Segment Held Largest Share by Type in APAC Mid-Size Pharmaceutical Market

Figure 5.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           APAC Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028

Figure 8.           APAC Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

Figure 9.           APAC Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        APAC Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        APAC Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

Figure 12.        APAC In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        APAC Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        APAC Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

Figure 15.        APAC Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        APAC Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        APAC Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        APAC Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

Figure 20.        APAC Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        APAC Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        APAC Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        APAC Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        APAC Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Mid-Size Pharmaceutical Market, by Key Country – Revenue (2022) (USD Million)

Figure 26.        APAC: Mid-Size Pharmaceutical Market, by Country, 2022 & 2028 (%)

Figure 27.        China: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Japan: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        India: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Australia: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        South Korea: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Rest of APAC: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Growth Strategies Done by the Companies in the Market, (%)